Modeling spontaneous metastatic renal cell carcinoma (mRCC) in mice following nephrectomy

Amanda Tracz, Michalis Mastri, Christina R. Lee, Roberto Pili, John M.L. Ebos

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

One of the key challenges to improved testing of new experimental therapeutics in renal cell carcinoma (RCC) is the development of models that faithfully recapitulate early- and late-stage metastatic disease progression. Typical tumor implantation models utilize ectopic or orthotopic primary tumor implantation, but few include systemic spontaneous metastatic disease that mimics the clinical setting. This protocol describes the key steps to develop RCC disease progression stages similar to patients. First, it uses a highly metastatic mouse tumor cell line in a syngeneic model to show orthotopic tumor cell implantation. Methods include superficial and internal implantation into the sub-capsular space with cells combined with matrigel to prevent leakage and early spread. Next it describes the procedures for excision of tumor-bearing kidney (nephrectomy), with critical pre- and post- surgical mouse care. Finally, it outlines the steps necessary to monitor and assess micro-and macro-metastatic disease progression, including bioluminescent imaging as well provides a detailed visual necropsy guide to score systemic disease distribution. The goal of this protocol description is to facilitate the widespread use of clinically relevant metastatic RCC models to improve the predictive value of future therapeutic testing. 

Original languageEnglish (US)
JournalJournal of visualized experiments : JoVE
Issue number86
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Nephrectomy
Renal Cell Carcinoma
Tumors
Cells
Disease Progression
Neoplasms
Bearings (structural)
Network protocols
Tumor Cell Line
Testing
Macros
Kidney
Therapeutics
Imaging techniques

ASJC Scopus subject areas

  • Neuroscience(all)
  • Chemical Engineering(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Modeling spontaneous metastatic renal cell carcinoma (mRCC) in mice following nephrectomy. / Tracz, Amanda; Mastri, Michalis; Lee, Christina R.; Pili, Roberto; Ebos, John M.L.

In: Journal of visualized experiments : JoVE, No. 86, 2014.

Research output: Contribution to journalArticle

@article{3ff61d8974d64a8ab5c71282518644dd,
title = "Modeling spontaneous metastatic renal cell carcinoma (mRCC) in mice following nephrectomy",
abstract = "One of the key challenges to improved testing of new experimental therapeutics in renal cell carcinoma (RCC) is the development of models that faithfully recapitulate early- and late-stage metastatic disease progression. Typical tumor implantation models utilize ectopic or orthotopic primary tumor implantation, but few include systemic spontaneous metastatic disease that mimics the clinical setting. This protocol describes the key steps to develop RCC disease progression stages similar to patients. First, it uses a highly metastatic mouse tumor cell line in a syngeneic model to show orthotopic tumor cell implantation. Methods include superficial and internal implantation into the sub-capsular space with cells combined with matrigel to prevent leakage and early spread. Next it describes the procedures for excision of tumor-bearing kidney (nephrectomy), with critical pre- and post- surgical mouse care. Finally, it outlines the steps necessary to monitor and assess micro-and macro-metastatic disease progression, including bioluminescent imaging as well provides a detailed visual necropsy guide to score systemic disease distribution. The goal of this protocol description is to facilitate the widespread use of clinically relevant metastatic RCC models to improve the predictive value of future therapeutic testing. ",
author = "Amanda Tracz and Michalis Mastri and Lee, {Christina R.} and Roberto Pili and Ebos, {John M.L.}",
year = "2014",
doi = "10.3791/51485",
language = "English (US)",
journal = "Journal of Visualized Experiments",
issn = "1940-087X",
publisher = "MYJoVE Corporation",
number = "86",

}

TY - JOUR

T1 - Modeling spontaneous metastatic renal cell carcinoma (mRCC) in mice following nephrectomy

AU - Tracz, Amanda

AU - Mastri, Michalis

AU - Lee, Christina R.

AU - Pili, Roberto

AU - Ebos, John M.L.

PY - 2014

Y1 - 2014

N2 - One of the key challenges to improved testing of new experimental therapeutics in renal cell carcinoma (RCC) is the development of models that faithfully recapitulate early- and late-stage metastatic disease progression. Typical tumor implantation models utilize ectopic or orthotopic primary tumor implantation, but few include systemic spontaneous metastatic disease that mimics the clinical setting. This protocol describes the key steps to develop RCC disease progression stages similar to patients. First, it uses a highly metastatic mouse tumor cell line in a syngeneic model to show orthotopic tumor cell implantation. Methods include superficial and internal implantation into the sub-capsular space with cells combined with matrigel to prevent leakage and early spread. Next it describes the procedures for excision of tumor-bearing kidney (nephrectomy), with critical pre- and post- surgical mouse care. Finally, it outlines the steps necessary to monitor and assess micro-and macro-metastatic disease progression, including bioluminescent imaging as well provides a detailed visual necropsy guide to score systemic disease distribution. The goal of this protocol description is to facilitate the widespread use of clinically relevant metastatic RCC models to improve the predictive value of future therapeutic testing. 

AB - One of the key challenges to improved testing of new experimental therapeutics in renal cell carcinoma (RCC) is the development of models that faithfully recapitulate early- and late-stage metastatic disease progression. Typical tumor implantation models utilize ectopic or orthotopic primary tumor implantation, but few include systemic spontaneous metastatic disease that mimics the clinical setting. This protocol describes the key steps to develop RCC disease progression stages similar to patients. First, it uses a highly metastatic mouse tumor cell line in a syngeneic model to show orthotopic tumor cell implantation. Methods include superficial and internal implantation into the sub-capsular space with cells combined with matrigel to prevent leakage and early spread. Next it describes the procedures for excision of tumor-bearing kidney (nephrectomy), with critical pre- and post- surgical mouse care. Finally, it outlines the steps necessary to monitor and assess micro-and macro-metastatic disease progression, including bioluminescent imaging as well provides a detailed visual necropsy guide to score systemic disease distribution. The goal of this protocol description is to facilitate the widespread use of clinically relevant metastatic RCC models to improve the predictive value of future therapeutic testing. 

UR - http://www.scopus.com/inward/record.url?scp=85005847965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85005847965&partnerID=8YFLogxK

U2 - 10.3791/51485

DO - 10.3791/51485

M3 - Article

JO - Journal of Visualized Experiments

JF - Journal of Visualized Experiments

SN - 1940-087X

IS - 86

ER -